可溶性CD40配体通过长链非编码RNA linc00239对THP-1细胞生物学行为的影响

封忠昕,李梅

PDF(1450 KB)
PDF(1450 KB)
吉林大学学报(医学版) ›› 2024, Vol. 50 ›› Issue (1) : 88-96. DOI: 10.13481/j.1671-587X.20240111
基础研究

可溶性CD40配体通过长链非编码RNA linc00239对THP-1细胞生物学行为的影响

  • 封忠昕(),李梅
作者信息 +

Effect of soluble CD40 ligand on biological behavior of THP-1 cells through long non-coding RNA linc00239

  • Zhongxin FENG(),Mei LI
Author information +
History +

摘要

目的 探讨CD40配体(CD40L)通过长链非编码RNA(lncRNA) linc00239对人单核细胞白血病THP-1细胞生物学行为的影响,阐明其可能的作用机制。 方法 构建linc00239过表达载体(pcDNA-linc00239)和干扰载体(sh-linc00239),转染至THP-1细胞,采用实时荧光定量PCR(RT-qPCR)法检测转染效率。THP-1细胞分为对照组、空载体(vector)组、pcDNA-linc00239组、sh-linc00239组、vector+CD40L组、pcDNA-linc00239+CD40L组和sh-linc00239+CD40L组。RT-qPCR法检测各组细胞中linc00239表达水平,CCK-8法检测各组细胞增殖活性,流式细胞术检测各组不同细胞周期细胞百分率和细胞凋亡率,RT-qPCR法和Western blotting法检测各组细胞中B细胞淋巴瘤2(Bcl-2)和Bcl-2关联X蛋白(Bax)mRNA和蛋白表达水平,Western blotting法检测各组细胞中蛋白激酶B(AKT)和磷酸化AKT(p-AKT)蛋白表达水平并计算p-AKT/AKT比值。 结果 与vector组比较,pcDNA-linc00239组细胞增殖活性和G2期细胞百分率明显升高(P<0.05或P<0.01),细胞中linc00239、Bcl-2 mRNA及蛋白表达水平和p-AKT/AKT比值明显升高(P<0.05或P<0.01),G1期细胞百分率、细胞凋亡率和细胞中Bax mRNA及蛋白表达水平明显降低(P<0.05);与vector组比较,sh-linc00239组和vector+CD40L组细胞增殖活性和G2期细胞百分率明显降低(P<0.05或P<0.01),细胞中linc00239、Bcl-2 mRNA和蛋白表达水平及p-AKT/AKT比值明显降低(P<0.05或P<0.01),G1期细胞百分率、细胞凋亡率和细胞中Bax mRNA及蛋白表达水平明显升高(P<0.05或P<0.01)。与pcDNA-linc00239组比较,pcDNA-linc00239+CD40L组细胞增殖活性和G2期细胞百分率明显降低(P<0.05或P<0.01),细胞中linc00239、Bcl-2 mRNA和蛋白表达水平及p-AKT/AKT比值明显降低(P<0.05或P<0.01),G1期细胞百分率、细胞凋亡率和细胞中Bax mRNA及蛋白表达水平明显升高(P<0.05或P<0.01);与sh-linc00239组比较,sh-linc00239+CD40L组细胞增殖活性和G2期细胞百分率明显降低(P<0.05或P<0.01),细胞中linc00239、Bcl-2 mRNA和蛋白表达水平及p-AKT/AKT比值明显降低(P<0.05或P<0.01),G1期细胞百分率、细胞凋亡率和细胞中Bax mRNA及蛋白表达水平明显升高(P<0.05或P<0.01)。 结论 CD40L可通过linc00239抑制THP-1细胞增殖和细胞周期进展,并诱导细胞凋亡。

Abstract

Objective To discuss the effect of CD40 ligand (CD40L) on the biological behavior of the human monocytic leukemia THP-1 cells through long non-coding RNA(lncRNA) linc00239,and to clarify its potential mechanism. Methods The linc00239 over-expression vector (pcDNA-linc00239) and interference vector (sh-linc00239) were constructed and transfected into the THP-1 cells.Real-time fluorescence quantitative PCR (RT-qPCR) method was used to detect the transfection efficiency. The THP-1 cells were divided into control group, vector group, pcDNA-linc00239 group, sh-linc00239 group, vector+CD40L group, pcDNA-linc00239+CD40L group, and sh-linc00239+CD40L group. RT-qPCR method was used to detect the expression levels of linc00239 in the cells in various groups; CCK-8 assay was used to detect the proliferation activities of the cells in various groups;flow cytometry was used to detect the percentages of the cells at different cell cycles and the apoptotic rates of the cells in various groups;RT-qPCR and Western blotting methods were used to to detect the expression levels of B-cell lymphoma-2 (Bcl-2) and Bcl-2-associated X protein (Bax) mRNA and proteins in the cells in various groups; Western blotting method was used to detect the expression levels of protein kinase B (AKT) and phosphorylated AKT (p-AKT) proteins in the cells in various groups,and the ratio of p-AKT/AKT was calculated. Results Compared with vector group, the proliferation activity of the cells and the percentage of the cells at G2 phase in pcDNA-linc00239 group were significantly increased (P<0.05 or P<0.01), the expression levels of linc00239, Bcl-2 mRNA and protein, and the ratio of p-AKT/AKT were significantly increased (P<0.05 or P<0.01),the percentage of the cells at G1 phase, apoptotic rate, and expression levels of Bax mRNA and protein in the cells were significantly decreased (P<0.05); compared with vector group, the proliferation activity of the cells and percentage of the cells at G2 phase, expression levels of linc00239, Bcl-2 mRNA and protein, and ratio of p-AKT/AKT in the cells in sh-linc00239 group and vector+CD40L group were significantly decreased (P<0.05 or P<0.01), while the percentage of the cells at G1 phase, apoptotic rate, and the expression levels of Bax mRNA and protein in the cells were significantly increased (P<0.05 or P<0.01);compared with pcDNA-linc00239 group, the proliferation activity of the cells and percentage of cells at G2 phase in pcDNA-linc00239+CD40L group were significantly decreased (P<0.05 or P<0.01), the expression levels of linc00239, Bcl-2 mRNA and protein,and ratio of p-AKT/AKT were significantly decreased (P<0.05 or P<0.01),while the percentage of cells at G1 phase, apoptotic rate, and the expression levels of Bax mRNA and protein were significantly increased (P<0.05 or P<0.01);compared with sh-linc00239 group, the proliferation activity of the cells and percentage of cells at G2 phase in sh-linc00239+CD40L group were significantly decreased (P<0.05 or P<0.01), the expression levels of linc00239, Bcl-2 mRNA and protein, and ratio of p-AKT/AKT were significantly decreased (P<0.05 or P<0.01),and the percentage of the cells at G1 phase, apoptotic rate, and expression levels of Bax mRNA and protein were significantly increased (P<0.05 or P<0.01). Conclusion CD40L can inhibit the proliferation and cell cycle progression of the THP-1 cells through linc00239 and induce the apoptosis.

关键词

CD40配体 / 长链非编码RNA / linc00239 / 急性髓系白血病 / 细胞周期 / 细胞凋亡

Key words

CD40 ligand / Long non-coding RNA / linc00239 / Acute myeloid leukemia / Cell cycle / Apoptosis

中图分类号

R733.71

引用本文

导出引用
封忠昕,李梅. 可溶性CD40配体通过长链非编码RNA linc00239对THP-1细胞生物学行为的影响. 吉林大学学报(医学版). 2024, 50(1): 88-96 https://doi.org/10.13481/j.1671-587X.20240111
Zhongxin FENG,Mei LI. Effect of soluble CD40 ligand on biological behavior of THP-1 cells through long non-coding RNA linc00239[J]. Journal of Jilin University(Medicine Edition). 2024, 50(1): 88-96 https://doi.org/10.13481/j.1671-587X.20240111

参考文献

1 NEWELL L F, COOK R J. Advances in acute myeloid leukemia[J]. BMJ, 2021, 375: n2026.
2 DINARDO C, LACHOWIEZ C. Acute myeloid leukemia: from mutation profiling to treatment decisions[J].Curr Hematol Malig Rep,2019,14(5): 386-394.
3 TAKAMI A. Hematopoietic stem cell transplantation for acute myeloid leukemia[J].Int J Hematol,2018,107(5): 513-518.
4 KARNELL J L, RIEDER S A, ETTINGER R, et al. Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond[J]. Adv Drug Deliv Rev, 2019, 141: 92-103.
5 封忠昕, 陈 琦, 王永伦, 等. 可溶性CD40配体对白血病HL-60细胞Caspase-3及Caspase-8表达的影响[J]. 中华肿瘤防治杂志, 2016, 23(19): 1287-1290.
6 封忠昕, 陈 琦, 闵 迅, 等. 可溶性CD40配体对白血病THP-1细胞的影响及机制[J]. 中国老年学杂志, 2018, 38(14): 3472-3474.
7 FENG Z X, CHEN Q, REN M Q, et al. CD40L inhibits cell growth of THP-1 cells by suppressing the PI3K/Akt pathway[J]. Onco Targets Ther, 2019, 12: 3011-3017.
8 FENG Z X, CHEN Q. Raised CD40L expression attenuates drug resistance in Adriamycin-resistant THP-1 cells[J].Exp Ther Med,2020,19(3):2188-2194.
9 YANG Y T, DAI W S, SUN Y W, et al. Long non?coding RNA linc00239 promotes malignant behaviors and chemoresistance against doxorubicin partially via activation of the PI3K/Akt/mTOR pathway in acute myeloid leukaemia cells[J]. Oncol Rep, 2019, 41(4): 2311-2320.
10 封忠昕, 陈 琦, 王季石, 等. 可溶性CD40配体对白血病THP-1细胞生物学影响及机制研究[J]. 中华肿瘤防治杂志, 2019, 26(10): 690-694.
11 SAUER T, ROONEY C M. Current challenges for CAR T-cell therapy of acute myeloid leukemia[J]. Transfusion, 2019, 59(4): 1171-1173.
12 LIN W Y, ZHOU Q Y, WANG C Q, et al. LncRNAs regulate metabolism in cancer[J]. Int J Biol Sci, 2020, 16(7): 1194-1206.
13 PENG W X, KOIRALA P, MO Y Y. LncRNA-mediated regulation of cell signaling in cancer[J]. Oncogene, 2017, 36(41): 5661-5667.
14 DONJERKOVIC D, SCOTT D W. Regulation of the G1 phase of the mammalian cell cycle[J]. Cell Res, 2000, 10(1): 1-16.
15 YANG R, DONG H, JIA S, et al. Resveratrol as a modulatory of apoptosis and autophagy in cancer therapy[J]. Clin Transl Oncol, 2022, 24(7):1219-1230.
16 DAS S, SHUKLA N, SINGH S S, et al. Mechanism of interaction between autophagy and apoptosis in cancer[J]. Apoptosis, 2021, 26(9/10): 512-533.
17 RAHMANI M, NKWOCHA J, HAWKINS E, et al. Cotargeting BCL-2 and PI3K induces BAX-dependent mitochondrial apoptosis in AML cells[J]. Cancer Res, 2018, 78(11): 3075-3086.
18 EDLICH F. BCL-2 proteins and apoptosis: recent insights and unknowns[J]. Biochem Biophys Res Commun, 2018, 500(1): 26-34.
19 LIU L, YANG L, LIU X J, et al. SEMA4D/PlexinB1 promotes AML progression via activation of PI3K/Akt signaling[J]. J Transl Med, 2022, 20(1): 304.
20 LIU H C, HUSSAIN Z, XIE Q Q, et al. Targeting PI3K/AKT/mTOR pathway to enhance the anti-leukemia efficacy of venetoclax[J]. Exp Cell Res, 2022, 417(2): 113192.
21 NOOROLYAI S, SHAJARI N, BAGHBANI E, et al. The relation between PI3K/AKT signalling pathway and cancer[J]. Gene, 2019, 698: 120-128.
22 张 靖, 冯晓杰, 白惠娟. lncRNA PTPRG-AS1通过调控PI3K/Akt信号通路对卵巢癌细胞增殖和凋亡的影响[J].郑州大学学报(医学版),2021,56(2):275-279.

基金

贵州省卫健委科学技术基金项目(gzwjkj2020-1-082)

评论

PDF(1450 KB)

Accesses

Citation

Detail

段落导航
相关文章

/